A phase II study of hypofractionated proton therapy for prostate cancer.
Kim YJ, Cho KH, Pyo HR, Lee KH, Moon SH, Kim TH, Shin KH, Kim JY, Lee SB, Nam BH.
Kim YJ, et al. Among authors: cho kh.
Acta Oncol. 2013 Apr;52(3):477-85. doi: 10.3109/0284186X.2013.764011. Epub 2013 Feb 11.
Acta Oncol. 2013.
PMID: 23398594
Clinical Trial.